Zheng Bingbing, Tian Yang, Liu Senyao, Yang Jieyu, Wu Fapu, Xiong Hu
Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China.
Anal Chem. 2023 Aug 15;95(32):12054-12061. doi: 10.1021/acs.analchem.3c02005. Epub 2023 Aug 1.
Noninvasive visualization of liver polarity by using fluorescence imaging technology is helpful to better understand drug-induced liver injury (DILI). However, cell membrane-targeted polarity-sensitive near-infrared (NIR) fluorescent probes are still scarce. Herein, we report a non-solvatochromic cell membrane-targeted NIR small molecular probe () for monitoring the polarity changes on cell membranes in living cells and in vivo. exhibits polarity-dependent fluorescence around 655 nm without an obvious solvatochromic effect, which endows it with good capability for the in vivo imaging study. Moreover, it can rapidly and selectively light up the cell membranes as well as distinguish tumor cells from normal cells due to its excellent polarity-sensitive ability. More importantly, has been successfully applied to visualize liver polarity changes in vivo, revealing the reduction of liver polarity in DILI mice. We believe that provides a new way for the diagnosis of DILI.
利用荧光成像技术对肝脏极性进行无创可视化有助于更好地理解药物性肝损伤(DILI)。然而,细胞膜靶向的极性敏感近红外(NIR)荧光探针仍然稀缺。在此,我们报告了一种非溶剂化显色的细胞膜靶向NIR小分子探针(),用于监测活细胞和体内细胞膜上的极性变化。在655nm左右表现出极性依赖性荧光,没有明显的溶剂化显色效应,这赋予了它良好的体内成像研究能力。此外,由于其出色的极性敏感能力,它可以快速、选择性地点亮细胞膜,并区分肿瘤细胞和正常细胞。更重要的是,已成功应用于体内可视化肝脏极性变化,揭示了DILI小鼠肝脏极性的降低。我们相信,为DILI的诊断提供了一种新方法。